Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for impaired hypoglycaemia awareness in type 1 diabetes
2016-000790-21Phase 2Completed
- Sponsor
- Radboudumc
- Start
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of exenatide in diabetes mellitus type 1 (T1D) and Hypoglycaemia unawareness (HU) (2 arms), sponsored by Radboudumc. Primary endpoint: Maximal symptom score during hypoglycaemic clamp. Started Sep 2016; status: completed.
02
Drugs
exenatide
03
Conditions
diabetes mellitus type 1 (T1D)Hypoglycaemia unawareness (HU)
Beyond the preview
Go deeper on 2016-000790-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000790-21.